Andrew Bartholomaeus

Andrew Bartholomaeus, B.Pharm, PhD, Cert Ag (III), obtained a bachelors degree in pharmacy from the University of Sydney and following professional practice in pharmaceutical manufacturing, hospital and military pharmacy completed a PhD in toxicology at RMIT University in Melbourne. Over the past 30 years Prof Bartholomaeus has worked as a toxicologist across a broad range of chemical regulatory areas including agricultural, veterinary and industrial chemicals, complementary medicines, gene technology products and food. Prior to June 2008 he held the position of Chief Toxicologist with the Prescription Medicines area of the Therapeutic Goods Administration in Australia with responsibilities in the area of preclinical assessment and in leading the TGAs response to the Australian National Nanotechnology Strategy. Prof Bartholomaeus subsequently took up the position of General Manager of the Risk Assessment Branch at Food Standards Australia New Zealand. Prof Bartholomaeus retired from FSANZ in 2012 to establish his own consultancy and to devote more time to research and teaching. He currently holds extramural appointments with FSANZ as a science fellow, the University of Queensland Medical School as an Adjunct Professor, the University of Canberra as an Adjunct Professor of Toxicology and Pharmacy, is an expert adviser to the FAO/WHO and was a member of the ILSI IFBiC Steering Group. In June 2009 Dr Bartholomaeus chaired the FAO/WHO Expert consultation on the Application of Nanotechnologies in the Food and Agriculture Sectors: Potential Food Safety Implications. Prof Bartholomaeus is a member of the Society of Toxicology and ACTRA.